©The Author(s) 2025.
World J Nephrol. Dec 25, 2025; 14(4): 109767
Published online Dec 25, 2025. doi: 10.5527/wjn.v14.i4.109767
Published online Dec 25, 2025. doi: 10.5527/wjn.v14.i4.109767
Table 4 Dose modifications of antiviral drugs recommended according to estimated glomerular filtration rate
| Antiviral drug | Creatinine clearance (mL per minute) | |||
| > 50 | 30-49 | 10-29 | < 10 or dialysis | |
| Tenofovir disoproxil fumarate | 300 mg tablet once a day | 300 mg tablet every 48 hours | 300 mg tablet every 72-96 hours | 300 mg tablet every seven days or following completion of dialysis |
| Entecavir | 0.5 mg tablet daily | 0.5 mg tablet every 48 hours | 0.5 mg tablet every 72 hours | 0.5 mg tablet every week |
| Tenofovir alafenamide | 25 mg tablet once a day | 25 mg tablet once a day | 25 mg tablet once a day up to creatinine clearance of 15 mL/minute | 25 mg tablet after completion of dialysis |
- Citation: Singh S, Singh R, Kaul A, Goel A. Hepatitis B and chronic kidney disease: Bench to bedside. World J Nephrol 2025; 14(4): 109767
- URL: https://www.wjgnet.com/2220-6124/full/v14/i4/109767.htm
- DOI: https://dx.doi.org/10.5527/wjn.v14.i4.109767